Industry Self-Regulation Group Sends Questions About PLx Pharma’s Vazalore Claims To FTC
Executive Summary
Over past year, PLx's Vazalore ad claimswere reviewed National Advertising Division before and after launch. As PLx appeals NAD’s post-launch review findings, NAD attorneys send questions about pre-launch claims to FTC.